SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-197112
Filing Date
2014-05-13
Accepted
2014-05-13 16:30:59
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d700030d10q.htm 10-Q 240859
2 EX-31.1 d700030dex311.htm EX-31.1 9461
3 EX-31.2 d700030dex312.htm EX-31.2 9462
4 EX-32.1 d700030dex321.htm EX-32.1 4904
5 EX-32.2 d700030dex322.htm EX-32.2 4905
  Complete submission text file 0001193125-14-197112.txt   2654362

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20140331.xml EX-101.INS 221105
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20140331.xsd EX-101.SCH 35124
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20140331_cal.xml EX-101.CAL 39248
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20140331_def.xml EX-101.DEF 200486
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20140331_lab.xml EX-101.LAB 285695
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20140331_pre.xml EX-101.PRE 235862
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 14837757
SIC: 2834 Pharmaceutical Preparations